Zobrazeno 1 - 10
of 71
pro vyhledávání: '"M A MASCHAN"'
Autor:
D A SHASHELEVA, A A MASCHAN, L N SHELIKHOVA, U N PETROVA, E E KURNIKOVA, O I ILLARIONOVA, E V BOYAKOVA, G A NOVICHKOVA, M A MASCHAN
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 57-64 (2018)
The main goal is to optimize hematopoietic stem cell transplantation (HSCT) approach among adolescents and young adults with paroxysmal nocturnal hemoglobinuria (PNH) by means of Graft-versus-host disease (GVHD) and post-transplant complications risk
Externí odkaz:
https://doaj.org/article/c5aa744b838d4ea0acb3b3e7f77cb253
Autor:
Y Y DYAKONOVA, O I BYDANOV, A M POPOV, Y V OLSHANSKAYA, E G BOICHENKO, O V ALEYNIKOVA, M A MASCHAN, L N SHELIKHOVA, D V LITVINOV, L A KHACHATRYAN, N I PONOMAREVA, L G FECHINA, G A NOVICHKOVA, E D PASHANOV, A I KARACHUNSKIY
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 37-50 (2018)
Aim. The analysis of experience of nelarabine use in refractory/relapsed T-cell acute lymphoblastic leukemia (T-ALL) depending on the immunophenotype and the line of therapy. Materials and methods. All the patients with relapsed or refractory T-ALL a
Externí odkaz:
https://doaj.org/article/8277c105b38f465fa2bd4074aac1eb65
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 51-56 (2017)
Aim. To evaluate the safety and efficacy of crizotinib used in pediatric patients with relapsed or refractory ALK-positive anaplastic large-cell lymphoma (ALCL). Subjects and methods. The paper describes the experience with crizotinib used in 8 patie
Externí odkaz:
https://doaj.org/article/bce54223605a4221addab074adf38d3e
Autor:
G A Novichkova, M A Maschan, I P Shipitsyna, Yu V Skvortsova, M I Persiantseva, L L Lebedeva, V O Bobrynina, D D Baidildina, O V Goronkova, G G Solopova, L A Khachatryan, U N Petrova, E V Suntsova, I I Kalinina, V V Sinitsyna, E V Skorobogatova, D N Balashov, Z M Dyshlevaya, L N Shelikhova, E E Kurnikova, P E Trakhtman, A A Maschan
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 41-47 (2010)
Aim. To analyze the efficiency of transplantation of the bone marrow from a HLA-compatible unrelated donor and continued immunosuppressive therapy (IST) in children with aplastic anemia (AA) unresponsive to 2 courses of IST. Subjects and methods. The
Externí odkaz:
https://doaj.org/article/a539b74b2830479ca8268ed25335826e
Autor:
Z M Dyshlevaya, E V Skorobogatova, M A Maschan, I P Shipitsyna, Yu V Skvortsova, P E Trakhtman, D N Balashov, Yu V Pashko, E E Kurnikova, E V Suntsova, O V Goronkova, G G Solopova, D D Baidildina, I I Kalinina, L A Khachatryan, M M Shneider, A A Maschan
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 34-40 (2010)
Aim. To analyze the results of allogeneic and autologous hemopoietic cell transplantations (allo- and auto-HCT) in children with acute myeloid leukemia (AML) from an intermediate risk group, most of which were performed using lower-intensity conditio
Externí odkaz:
https://doaj.org/article/10dd86ccbaa341b7856c227fcea1b525
Autor:
D D Baidildina, M A Maschan, E V Skorobogatova, M E Dubrovina, Yu V Rumyantseva, A A Maschan, A G Rumyantsev, E V Samochatova
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 20-25 (2010)
Aim. To analyze the specific features of recurrences of acute promyelocytic leukemia (APL) in children after standard therapy with daunorubicin, cytosine arabinoside (Ara-C), all-trans retinoic acid (ATRA) and to develop further programmed treatment
Externí odkaz:
https://doaj.org/article/5e62b3f9a57b4cd8bfe665f6abeecb61
Autor:
E. V. Volchkov, A. A. Khozyainova, M. Kh. Gurzhikhanova, I. V. Larionova, V. E. Matveev, D. A. Evseev, A. K. Ignatova, M. E. Menyailo, D. A. Venyov, R. S. Vorobev, A. A. Semchenkova, Yu. V. Olshanskaya, E. V. Denisov, M. A. Maschan
Publikováno v:
npj Systems Biology and Applications, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Juvenile myelomonocytic leukemia (JMML) is a rare myeloproliferative disease of early childhood that develops due to mutations in the genes of the RAS-signaling pathway. Next-generation high throughput sequencing (NGS) enables identification
Externí odkaz:
https://doaj.org/article/8653776d94114edea55191f30c4446f9
Autor:
V. M. Ukrainskaya, O. E. Musatova, D. V. Volkov, D. S. Osipova, D. S. Pershin, A. M. Moysenovich, E. G. Evtushenko, E. A. Kulakovskaya, E. G. Maksimov, H. Zhang, Y. P. Rubtsov, M. A. Maschan, A. V. Stepanov, A. G. Gabibov
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Tumor-derived extracellular vesicles (EVs) are active contributors in metastasis and immunosuppression in tumor microenvironment. At least some of the EVs carry tumor surface molecules such as tumor-associated antigens (TAAs) and/or checkpoi
Externí odkaz:
https://doaj.org/article/2cb173f3f63b4d86a4068a2d2e7d646a
Autor:
M. A. Maschan, N. V. Myakova
Publikováno v:
Онкогематология, Vol 0, Iss 1-2, Pp 50-63 (2022)
Externí odkaz:
https://doaj.org/article/9b8fce61f19a4307a7466339a8100122
Autor:
E. V. Samochatova, D. D. Baidildina, M. A. Maschan, N. N. Savva, O. P. Khlebnikova, A. V. Shamardina, Yu. E. Mareiko, G. A. Tsaur, T. O. Riger, M. M. Shneider, Yu. V. Rumyantseva, T. V. Nasedkina, T. V. Savitskaya, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 8-17 (2022)
The use of all-trans retinoic acid (ATRA) drastically improved the results of therapy for acute promyelocytic leukeimia (APL). The high efficiency of the Russian protocol APL-93—98 applied to 62 children and adolescents with APL (event-free and ove
Externí odkaz:
https://doaj.org/article/a1999c503e6849b689ddc0507d049b22